» Articles » PMID: 29544034

SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity Than SpCas9 or FnCpf1 in Human Cells

Overview
Journal Biotechnol J
Specialty Biotechnology
Date 2018 Mar 16
PMID 29544034
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Efficient genome editing in medaka () using a codon-optimized SaCas9 system.

Jiang Y, Pan Q, Wang Z, Lu K, Xia B, Chen T J Zhejiang Univ Sci B. 2025; 25(12):1083-1096.

PMID: 39743295 PMC: 11693391. DOI: 10.1631/jzus.B2300899.


A temperature-sensitive and less immunogenic Sendai virus for efficient gene editing.

Stevens C, Carmichael J, Watkinson R, Kowdle S, Reis R, Hamane K J Virol. 2024; 98(12):e0083224.

PMID: 39494910 PMC: 11650993. DOI: 10.1128/jvi.00832-24.


Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy.

de Morais C, Correia E, Bonamino M, Vasconcelos Z Hum Gene Ther. 2024; 35(19-20):781-797.

PMID: 39276086 PMC: 11511780. DOI: 10.1089/hum.2024.020.


A temperature-sensitive and interferon-silent Sendai virus vector for CRISPR-Cas9 delivery and gene editing in primary human cells.

Stevens C, Carmichael J, Watkinson R, Kowdle S, Reis R, Hamane K bioRxiv. 2024; .

PMID: 38746439 PMC: 11092779. DOI: 10.1101/2024.05.03.592383.


A CRISPRi-based genetic resource to study essential genes.

Reed P, Sorg M, Alwardt D, Serra L, Veiga H, Schaper S mBio. 2023; 15(1):e0277323.

PMID: 38054745 PMC: 10870820. DOI: 10.1128/mbio.02773-23.